Literature DB >> 11419584

Needle-exchange participation, effectiveness, and policy: syringe relay, gender, and the paradox of public health.

T W Valente1, R K Foreman, B Junge, D Vlahov.   

Abstract

Needle-exchange programs (NEPs) have been politically controversial, and most studies have focused on evaluating their effectiveness on human immunodeficiency virus (HIV) transmission rates with little emphasis on the process of how they are used. This article shows that the way intravenous drug users use NEPs may influence their effectiveness. Using data from Baltimore's NEP, participants (N = 2,574) were classified as low, medium, and high users based on the volume, frequency, and duration of contact with the NEP. Higher NEP use was associated with shorter syringe circulation times and less syringe relay, returning syringes to the NEP originally acquired by someone else. For a subsample that was HIV tested (N = 262), syringe relay among women was associated with HIV seroconversion (at a 95% confidence interval). We conclude that exclusive use of the NEP (no relay) provides greater HIV protection than NEP use involving syringe relay. The paradox is that public health goals will not be achieved by prohibiting syringe relay activities and promoting exclusive use. NEPs should broaden their education efforts to have participants understand the value of repeated visits to the NEP.

Entities:  

Mesh:

Year:  2001        PMID: 11419584      PMCID: PMC3456352          DOI: 10.1093/jurban/78.2.340

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  15 in total

1.  Evaluating needle exchange: do distributed needles come back?

Authors:  J Guydish; G Clark; D Garcia; M Downing; P Case; J L Sorensen
Journal:  Am J Public Health       Date:  1991-05       Impact factor: 9.308

2.  HIV prevalence among intravenous drug users: model-based estimates from New Haven's legal needle exchange.

Authors:  E H Kaplan; R Heimer
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

Review 3.  On the importance of peer influence for adolescent drug use: commonly neglected considerations.

Authors:  K E Bauman; S T Ennett
Journal:  Addiction       Date:  1996-02       Impact factor: 6.526

Review 4.  Syringe-mediated drug sharing among injecting drug users: patterns, social context and implications for transmission of blood-borne pathogens.

Authors:  J P Grund; S R Friedman; L S Stern; B Jose; A Neaigus; R Curtis; D C Des Jarlais
Journal:  Soc Sci Med       Date:  1996-03       Impact factor: 4.634

5.  Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program.

Authors:  D Vlahov; B Junge; R Brookmeyer; S Cohn; E Riley; H Armenian; P Beilenson
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-12-15

6.  Effectiveness of needle-exchange programmes for prevention of HIV infection.

Authors:  S F Hurley; D J Jolley; J M Kaldor
Journal:  Lancet       Date:  1997-06-21       Impact factor: 79.321

7.  Determinants of needle sharing among intravenous drug users.

Authors:  S Magura; J I Grossman; D S Lipton; Q Siddiqi; J Shapiro; I Marion; K R Amann
Journal:  Am J Public Health       Date:  1989-04       Impact factor: 9.308

8.  The role of needle exchanges in modifying sharing behaviour: cross-study comparisons 1989-1993.

Authors:  H Klee; J Morris
Journal:  Addiction       Date:  1995-12       Impact factor: 6.526

9.  The protective effect of AIDS-related behavioral change among injection drug users: a cross-national study. WHO Multi-Centre Study of AIDS and Injecting Drug Use.

Authors:  D C Des Jarlais; P Friedmann; H Hagan; S R Friedman
Journal:  Am J Public Health       Date:  1996-12       Impact factor: 9.308

10.  HIV incidence among injecting drug users in New York City syringe-exchange programmes.

Authors:  D C Des Jarlais; M Marmor; D Paone; S Titus; Q Shi; T Perlis; B Jose; S R Friedman
Journal:  Lancet       Date:  1996-10-12       Impact factor: 79.321

View more
  9 in total

1.  HIV among injection drug users in large US metropolitan areas, 1998.

Authors:  Samuel R Friedman; Spencer Lieb; Barbara Tempalski; Hannah Cooper; Marie Keem; Risa Friedman; Peter L Flom
Journal:  J Urban Health       Date:  2005-07-13       Impact factor: 3.671

2.  Hospital- versus community-based syringe exchange: a randomized controlled trial.

Authors:  Carmen L Masson; James L Sorensen; David C Perlman; Michael S Shopshire; Kevin L Delucchi; TeChieh Chen; Karl Sporer; Don Des Jarlais; Sharon M Hall
Journal:  AIDS Educ Prev       Date:  2007-04

3.  Spatial access to sterile syringes and the odds of injecting with an unsterile syringe among injectors: a longitudinal multilevel study.

Authors:  Hannah Cooper; Don Des Jarlais; Zev Ross; Barbara Tempalski; Brian H Bossak; Samuel R Friedman
Journal:  J Urban Health       Date:  2012-08       Impact factor: 3.671

4.  Decreased Odds of Injection Risk Behavior Associated With Direct Versus Indirect Use of Syringe Exchange: Evidence From Two California Cities.

Authors:  Czarina N Behrends; Chin-Shang Li; David R Gibson
Journal:  Subst Use Misuse       Date:  2017-05-30       Impact factor: 2.164

5.  Sexual relationships, secondary syringe exchange, and gender differences in HIV risk among drug injectors.

Authors:  Kara S Riehman; Alex H Kral; Rachel Anderson; Neil Flynn; Ricky N Bluthenthal
Journal:  J Urban Health       Date:  2004-06       Impact factor: 3.671

6.  Social network-related risk factors for bloodborne virus infections among injection drug users receiving syringes through secondary exchange.

Authors:  Prithwish De; Joseph Cox; Jean-François Boivin; Robert W Platt; Ann M Jolly
Journal:  J Urban Health       Date:  2007-11-24       Impact factor: 3.671

7.  The impact of needle-exchange programs on the spread of HIV among injection drug users: a simulation study.

Authors:  J M Raboud; M C Boily; J Rajeswaran; M V O'Shaughnessy; M T Schechter
Journal:  J Urban Health       Date:  2003-06       Impact factor: 3.671

8.  Assisted injection provider practices and motivations in Los Angeles and San Francisco California 2016-18.

Authors:  Sarah Brothers; Alex H Kral; Lynn Wenger; Kelsey Simpson; Ricky N Bluthenthal
Journal:  Int J Drug Policy       Date:  2020-11-28

Review 9.  Combination prevention: new hope for stopping the epidemic.

Authors:  Sten H Vermund; Richard J Hayes
Journal:  Curr HIV/AIDS Rep       Date:  2013-06       Impact factor: 5.071

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.